Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.
A recent study by Fred Hutch biochemist Christopher Lapointe, PhD, and his colleagues, uses innovative lab techniques to ...
At Fred Hutch, we bring the same level of commitment and integrity to our patients, donors and investors that we do to our clinical care and scientific research. We take our responsibility seriously, ...
A new statistical analysis of patients with follicular lymphoma, made possible by 15 years of follow-up data from a SWOG and ...
In this episode, Dr. Christina Baik shares her journey to Fred Hutch, her research on lung cancer, and the importance of patient-centered care and interdisciplinary collaboration in advancing cancer ...
Soheil Meshinchi, MD, PhD, a world leader in developing novel approaches to treating acute myeloid leukemia (AML), has been ...
Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of ...
Our mission is urgent: To unite innovative research and compassionate care to prevent and eliminate cancer and infectious disease. One way you can build a legacy of support for our mission is by ...
Dietary supplements aren’t just biological interventions; they’re psychological interventions, said Fred Hutch psychologist ...
Fred Hutch" CCEH Hematopoietic Cell Procurement and Processing is recognized as a leader in the field of acquisition, analysis, and enrichment of normal hematopoietic cells, this facility provides ...
Corporate partners have the opportunity to join our President’s Circle — a distinguished group of individuals and organizations committed to funding breakthroughs with annual gifts of $10,000 or more.
Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.